Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Armando de Oliveira Schubach is active.

Publication


Featured researches published by Armando de Oliveira Schubach.


The Journal of Infectious Diseases | 1998

Detection of Leishmania DNA by Polymerase Chain Reaction in Scars of Treated Human Patients

Armando de Oliveira Schubach; Fátima Haddad; Manoel Paes-Oliveira Neto; Wim Degrave; Claude Pirmez; Gabriel Grimaldi; Octavio Fernandes

Leishmaniasis is an endemic disease in developing countries. The efficacy of therapy is usually evaluated through clinical parameters. To define the parasitologic cure, 20 patients were biopsied before and 1 month to 8 years after treatment. Paraffin-embedded tissue was used for DNA isolation. All patients had a positive polymerase chain reaction (PCR) result before therapy, except 1, for whom no histopathologic material was available. The causative agent was identified as belonging to the Leishmania (Viannia) subgenus by hybridization. Despite clinical healing and absence of reactivation or development of mucosal lesions, PCR was positive in scars of 16 patients (80%). The results suggest that parasites persist in the skin for many years despite treatment. Depending on specific pathogenetic features of the parasite and the immune status of the host, this phenomenon might result in mucosal lesions. Alternatively, it could have a role in the maintenance of immunologic memory in patients living in areas in which leishmaniasis is endemic.


Memorias Do Instituto Oswaldo Cruz | 2001

Sporotrichosis: an emergent zoonosis in Rio de Janeiro

Mônica Bastos de Lima Barros; Tânia Maria Pacheco Schubach; Maria Clara Gutierrez Galhardo; Armando de Oliveira Schubach; Paulo Cezar Fialho Monteiro; Rosani Santos Reis; Rosely Maria Zancopé-Oliveira; Márcia dos Santos Lazéra; Tullia Cuzzi-Maya; Tânia Cristina Moita Blanco; Keyla Belizia Feldman Marzochi; Bodo Wanke; Antonio Carlos Francesconi do Valle

During the period from 1987 to 1998, 13 cases of human sporotrichosis were recorded at the Research Center Evandro Chagas Hospital (CPqHEC) in Rio de Janeiro. Two of these patients related scratch by a sick cat. During the subsequent period from July 1998 to July 2000, 66 human, 117 cats and 7 dogs with sporotrichosis were diagnosed at the CPqHEC. Fifty-two humans (78.8%) reported contact with cats with sporotrichosis, and 31 (47%) of them reporting a history of a scratch or bite. This epidemic, unprecedented in the literature, involving cats, dogs and human beings may have started insidiously before 1998.


Memorias Do Instituto Oswaldo Cruz | 1988

An outbreak of american cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janeiro city, Brazil: clinical and epidemiological studies

Manoel P. Oliveira-Neto; Claude Pirmez; Elizabeth Ferreira Rangel; Armando de Oliveira Schubach; Gabriel Grimaldi Júnior

From July 1984 to September 1986, 105 cases of American cutaneous leishmaniasis were studied in a locality closely situated to an urbanized area of the city of Rio de Janeiro, Brazil. Settlement in this area was established at least 20 years ago but the first cases were noted six months prior to the beginning of this study. Cases were almost exclusively cutaneous and ulcerated, with one to six months of evolution. Montenegros skin tests were positive in all cases and anti-Leishmania antibodies were detected by indirect immunofluorescence test in 74.3% of the patients. Parasites were demonstrated in 69.5% of cases. Domestic animals were easily found infected: 32% of the examined dogs and 30.8% of the examined equines were positive to the presence of Leishmania in cutaneous ulcerated lesions. Parasite isolates from human, dog and equines were immunologically characterized and identified as L. b. braziliensis. 73.0% of the sandfly population were Lutzomyia intermedia mainly caught on human baits and on domestic animals. Our observations suggest that this is an area of recent established L. b. braziliensis infection and that transmission probably occurs indoors or outdoors close to the houses.


Clinical Infectious Diseases | 2011

Treatment of Cutaneous Sporotrichosis With Itraconazole—Study of 645 Patients

Mônica Bastos de Lima Barros; Armando de Oliveira Schubach; Raquel de Vasconcellos Carvalhaes de Oliveira; Ezequias Martins; José Liporage Teixeira; Bodo Wanke

BACKGROUNDnItraconazole has become the first choice for treatment of cutaneous sporotrichosis. However, this recommendation is based on case reports and small series. The safety and efficacy of itraconazole were evaluated in 645 patients who received a diagnosis on the basis of isolation of Sporothrix schenckii in Rio de Janeiro, Brazil.nnnMETHODSnA standard regimen of itraconazole (100 mg/day orally) was used. Clinical and laboratory adverse events were assessed a grades 1-4. A multivariate Cox model was used to analyze the response to treatment.nnnRESULTSnThe median age was 43 years. Lymphocutaneous form occurred in 68.1% and fixed form in 23.1%. Six hundred ten patients (94.6%) were cured with itraconazole (50-400 mg/day): 547 with 100 mg/day, 59 with 200-400 mg/day, and 4 children with 50 mg/day. Three patients switched to potassium iodide, 2 to terbinafine, and 4 to thermotherapy. Twenty-six were lost to follow-up. Clinical adverse events occurred in 18.1% of patients using 100 mg/day and 21.9% of those using 200-400 mg/day. The most frequent clinical adverse events were nausea and epigastric pain. Laboratory adverse events occurred in 24.1%; the most common was hypercholesterolemia, followed by hypertriglyceridemia. Four hundred sixty-two patients (71.6%) completed clinical follow-up, and all remained cured. Only 2 variables were significant in explaining the cure: patients with erythema nodosum healed faster, and lymphocutaneous form took longer to cure.nnnCONCLUSIONSnIn the current series, the therapeutic response was excellent with the minimum dose of itraconazole, and there was a low incidence of adverse events and treatment failure.


International Journal of Dermatology | 1997

Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil – an area of Leishmania (V.) braziliensis transmission

M. P. Oliveira-Neto; Armando de Oliveira Schubach; Marise Mattos; Sylvio Celso Gonçalves da Costa; Claude Pirmez

Background The drug of choice for leishmaniasis is pentavalent antimony and different regimens are under continuous evaluation. The ideal therapy should be simple, effective, and with no or minor side‐effects, in this paper we have studied the efficacy of intralesionally applied antimony in New World cutaneous leishmaniasis.


Emerging Infectious Diseases | 2005

Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil.

Armando de Oliveira Schubach; Tânia Maria Pacheco Schubach; Mônica Bastos de Lima Barros; Bodo Wanke

Sporotrichosis is an emerging zoonosis in Rio de Janeiro, Brazil. From 1998 to 2003, 497 humans and 1,056 cats with culture-proven sporotrichosis were studied. A total of 421 patients, 67.4% with a history of a scratch or bite, reported contact with cats that had sporotrichosis.


Pediatric Infectious Disease Journal | 2008

Endemic of zoonotic sporotrichosis: profile of cases in children.

Mônica Bastos de Lima Barros; Débora Lucia Macedo Alves Costa; Tania Pacheco Schubach; Antonio Carlos Francesconi do Valle; Noemi Pereira Lorenzi; José Liporage Teixeira; Armando de Oliveira Schubach

Background: Sporotrichosis in childhood is rare in most countries. Isolated cases and small outbreaks related to recreational activities or without identification of the transmission mechanism have been reported. Methods: Series of case reports. The isolation of Sporothrix schenckii from exudates or fragments of lesions obtained from the patients was used as the criterion of inclusion in the study. Results: A total of 81 cases of sporotrichosis in children younger than 15 years of age were diagnosed at the Evandro Chagas Research Institute, Fiocruz, Brazil, between 1998 and 2004. These cases are part of the endemic disease occurring in Rio de Janeiro related to contact with domestic cats. There was a predominance of girls in the 10–14 year age group. The most frequent clinical form was the cutaneouslymphatic form located on the upper limbs. Itraconazole was used as the first-choice treatment. Sixty-six patients were cured, 9 were lost to follow-up, and 6 had spontaneous regression of the lesions. Conclusions: This is the largest series of childhood sporotrichosis with zoonotic transmission. The clinical presentation of sporotrichosis in children followed the same pattern of the disease in adults in this ongoing endemic.


Parasitology | 2009

Trypanosoma caninum n. sp. (Protozoa: Kinetoplastida) isolated from intact skin of a domestic dog (Canis familiaris) captured in Rio de Janeiro, Brazil.

Maria de Fátima Madeira; M. A. Sousa; J. H. S. Barros; Fabiano Borges Figueiredo; Aline Fagundes; Armando de Oliveira Schubach; C. C. De Paula; B. N. S. Faissal; T. S. Fonseca; H. K. Thoma; M. C. A. Marzochi

An unknown Trypanosoma species was isolated from an axenic culture of intact skin from a domestic dog captured in Rio de Janeiro, Brazil, which was co-infected with Leishmania (Viannia) braziliensis. Giemsa-stained smears of cultures grown in different media revealed the presence of epimastigotes, trypomastigotes, spheromastigotes, transitional stages, and dividing forms (epimastigotes or spheromastigotes). The highest frequency of trypomastigotes was observed in RPMI (15.2%) and DMEM (9.2%) media containing 5% FCS, with a mean length of these forms of 43.0 and 36.0 mum, respectively. Molecular analysis by sequential application of PCR assays indicated that this trypanosome differs from Trypanosoma cruzi and T. rangeli when specific primers were applied. On the other hand, a PCR strategy targeted to the D7 domain of 24salpha rDNA, using primers D75/D76, amplified products of about 250 bp in that isolate (stock A-27), different from the amplification products obtained with T. cruzi and T. rangeli. This organism differs from T. cruzi mainly by the size of its trypomastigote forms and kinetoplasts and the absence of infectivity for macrophages and triatomine bugs. It is also morphologically distinct from salivarian trypanosomes reported in Brazil. Isoenzyme analysis at 8 loci demonstrated a very peculiar banding pattern clearly distinct from those of T. rangeli and T. cruzi. We conclude that this isolate is a new Trypanosoma species. The name T. caninum is suggested.


Memorias Do Instituto Oswaldo Cruz | 2010

Evaluation of polymerase chain reaction in the routine diagnosis for tegumentary leishmaniasis in a referral centre.

Aline Fagundes; Armando de Oliveira Schubach; Cíntia Cristiane de Paula; Alessandra Bogio; Liliane de Fátima Antonio; Patrícia Botelho Schiavoni; Vivian de Souza Monteiro; Maria de Fátima Madeira; Leonardo Pereira Quintella; Cláudia Maria Valete-Rosalino; Érica de Camargo Ferreira e Vasconcellos; Rilza Beatriz Gayoso de Azeredo-Coutinho; Rachel S Pacheco; M. C. A. Marzochi; Keyla Bf Marzochi

The present study investigated the diagnostic value of polymerase chain reaction (PCR) performed in parallel to conventional methods at an American tegumentary leishmaniasis (ATL) referral centre for diagnosis. Accuracy parameters for PCR were calculated using 130 patients with confirmed ATL (ATL group), 15 patients established with other diseases and 23 patients with a lesion suggestive of ATL, but without parasitological confirmation (NDEF group). PCR showed 92.3% sensitivity, 93.3% specificity, a 99.2% positive predictive value and a 13.84 positive likelihood ratio. In the NDEF group, PCR confirmed ATL in 13 of the 23 patients, seven of whom responded to leishmaniasis treatment and six who presented spontaneous healing of the lesion. PCR should be included in the routine diagnostic procedures for ATL, especially for cases found to be negative by conventional methods.


Antimicrobial Agents and Chemotherapy | 2005

In Vitro Antifungal Susceptibilities of Sporothrix schenckii in Two Growth Phases

Luciana Trilles; Belkys Fernández-Torres; Márcia dos Santos Lazéra; Bodo Wanke; Armando de Oliveira Schubach; Rodrigo de Almeida Paes; Isabel Inza; Josep Guarro

ABSTRACT We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35°C) exerted a significant influence on the MICs.

Collaboration


Dive into the Armando de Oliveira Schubach's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cláudia Maria Valete-Rosalino

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bodo Wanke

Oswaldo Cruz Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge